These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9190559)

  • 21. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Another sudden death in a child treated with desipramine.
    Riddle MA; Geller B; Ryan N
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):792-7. PubMed ID: 8340300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth deficits and desipramine.
    Holt KG
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1167-8. PubMed ID: 1429424
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of attention deficit hyperactivity disorder: a critical review.
    Brown CS
    DICP; 1991 Nov; 25(11):1207-13. PubMed ID: 1763538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonstimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):373-83. PubMed ID: 15064003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
    Hornig M
    J Clin Psychiatry; 1998; 59 Suppl 7():69-75. PubMed ID: 9680055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tricyclic antidepressants - third-line treatment for attention deficit hyperactivity disorder in school-aged children.
    Bell G; Efron D
    J Paediatr Child Health; 2015 Dec; 51(12):1232-4. PubMed ID: 26633610
    [No Abstract]   [Full Text] [Related]  

  • 29. Attention-deficit/hyperactivity disorder: a neuropsychiatric disorder with childhood onset.
    Zuddas A; Ancilletta B; Muglia P; Cianchetti C
    Eur J Paediatr Neurol; 2000; 4(2):53-62. PubMed ID: 10817485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in the prevalence of chronic medication use in children: 2002-2005.
    Cox ER; Halloran DR; Homan SM; Welliver S; Mager DE
    Pediatrics; 2008 Nov; 122(5):e1053-61. PubMed ID: 18977954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterocyclic antidepressants in nonpsychiatric disorders.
    Siomopoulos V; Seneczko LO
    Am Fam Physician; 1984 Mar; 29(3):203-8. PubMed ID: 6702542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guanfacine use in children with attention deficit hyperactivity disorder.
    Cohn LM; Caliendo GC
    Ann Pharmacother; 1997; 31(7-8):918-9. PubMed ID: 9220058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonstimulant medications in the treatment of attention deficit hyperactivity disorder.
    Scahill L; French PT
    J Child Adolesc Psychiatr Nurs; 1996; 9(2):39-43. PubMed ID: 8868838
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychopharmacology of ADHD in adolescents.
    Greydanus DE; Sloane MA; Rappley MD
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
    Olfson M
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of desipramine response in younger and older women.
    Grigoriadis S; Bouffard BA; Kennedy S; Bagby RM; Joffe RT
    J Clin Psychopharmacol; 2010 Feb; 30(1):80-2. PubMed ID: 20075656
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
    Sangal JM; Sangal RB; Persky B
    Clin Electroencephalogr; 1996 Oct; 27(4):191-201. PubMed ID: 9465283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in alternative pharmacotherapy of ADHD.
    Pityaratstian N
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S357-62. PubMed ID: 16623055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.